Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maryam Zanjirband
Pre-Clinical Efficacy and Synergistic Potential of the MDM2-p53 Antagonists, Nutlin-3 and RG7388, as Single Agents and in Combined Treatment With Cisplatin in Ovarian Cancer
Oncotarget
Oncology
Related publications
Synergistic Antitumor Effects of Combined Deguelin and Cisplatin Treatment in Gastric Cancer Cells
Oncology Letters
Cancer Research
Oncology
A P53-Independent Role for the MDM2 Antagonist Nutlin-3 in DNA Damage Response Initiation
BMC Cancer
Cancer Research
Oncology
Genetics
HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the P53-Reactivating Drugs Nutlin-3 and RITA
Cancer Research
Cancer Research
Oncology
Treatment Options in Recurrent Ovarian Cancer: Latest Evidence and Clinical Potential
Therapeutic Advances in Medical Oncology
Oncology
The Sorafenib Plus Nutlin-3 Combination Promotes Synergistic Cytotoxicity in Acute Myeloid Leukemic Cells Irrespectively of FLT3 and P53 Status
Haematologica
Hematology
Efficacy of Aidi Injection Combined With Chemotherapy in the Treatment of Advanced Epithelial Ovarian Cancer
DEStech Transactions on Biology and Health
Telodendrimer Nanocarrier for Co-Delivery of Paclitaxel and Cisplatin: A Synergistic Combination Nanotherapy for Ovarian Cancer Treatment
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
ATM Dependent DUSP6 Modulation of P53 Involved in Synergistic Targeting of MAPK and P53 Pathways With Trametinib and MDM2 Inhibitors in Cutaneous Melanoma
Cancers
Cancer Research
Oncology
Synergistic Enhancement of Efficacy of Platinum Drugs With Verteporfin in Ovarian Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
